89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes.

Hematological and biochemical parameters were evaluated in 31 patients receiving 150 MBq 89Strontium (89Sr) intravenously due to painful skeletal metastases from hormone resistant prostate cancer. Two and 3 months after the injection prostate specific antigen (PSA) had increased by a median of 36% a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fosså, S. D., Paus, E., Lochoff, M., Backe, S. M., Aas, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977884/
https://www.ncbi.nlm.nih.gov/pubmed/1379058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977884/
https://www.ncbi.nlm.nih.gov/pubmed/1379058

Ejemplares similares